Trial Profile
Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Biomarker; Therapeutic Use
- 27 Nov 2015 New trial record